Analysts expect Perspective Therapeutics, Inc. to report revenue of 64,054.28 for Q3 26, against a range of 61,730.45 to 66,378.11. The most recent reported quarter, Q2 26, came in at 81,000.00, a 15.7% miss against the 96,048.71 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 369,000.00 | 234,000.00 | 342,000.00 | 290,000.00 | 209,000.00 | 43,000.00 | 76,000.00 | 81,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 321,663.61 | 283,046.63 | 150,322.34 | 231,606.02 | 251,818.42 | 233,231.37 | 161,175.94 | 103,957.94 | 66,378.11 | 69,254.48 | 140,263.56 | 93,329.61 | 63,497.89 | 60,107.13 | 333,816.58 | 229,195.24 | ||||||||||
| Low Estimate | 278,529.53 | 247,492.05 | 123,496.32 | 203,446.38 | 210,341.84 | 212,165.43 | 139,094.08 | 88,139.48 | 61,730.45 | 60,907.82 | 123,105.84 | 77,515.19 | 57,689.73 | 49,723.01 | 304,779.62 | 214,863.26 | ||||||||||
| Consensus Estimate | 300,096.57 | 265,269.34 | 136,909.33 | 217,526.20 | 231,080.13 | 222,698.40 | 150,135.01 | 96,048.71 | 64,054.28 | 65,081.15 | 131,684.70 | 85,422.40 | 60,593.81 | 54,915.07 | 319,298.10 | 222,029.25 |
Analysts expect Perspective Therapeutics, Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.25 to -0.21. The most recent reported quarter, Q2 26, came in at -0.22, a 18.5% beat against the -0.27 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.21 | -0.57 | -0.25 | -0.30 | -0.35 | -0.51 | -0.25 | -0.22 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.20 | -0.25 | -0.26 | -0.27 | -0.31 | -0.32 | -0.26 | -0.26 | -0.21 | -0.27 | -0.23 | -0.22 | -0.26 | -0.27 | -0.16 | -0.20 | ||||||||||
| Low Estimate | -0.22 | -0.31 | -0.30 | -0.29 | -0.35 | -0.38 | -0.30 | -0.28 | -0.25 | -0.29 | -0.25 | -0.26 | -0.30 | -0.31 | -0.18 | -0.22 | ||||||||||
| Consensus Estimate | -0.21 | -0.28 | -0.28 | -0.28 | -0.33 | -0.35 | -0.28 | -0.27 | -0.23 | -0.28 | -0.24 | -0.24 | -0.28 | -0.29 | -0.17 | -0.21 |
Pull Wall Street consensus for Perspective Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CATX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CATX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CATX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();